293 filings
8-K
ACST
Acasti Pharma Inc - Ordinary Shares
1 Apr 24
Regulation FD Disclosure
8:00am
8-K
ACST
Acasti Pharma Inc - Ordinary Shares
12 Feb 24
Acasti Announces Third Fiscal Quarter 2024 Financial Results and Business Highlights
8:00am
8-K
ACST
Acasti Pharma Inc - Ordinary Shares
8 Jan 24
Departure of Directors or Certain Officers
7:30am
8-K
ACST
Acasti Pharma Inc - Ordinary Shares
15 Dec 23
Changes in Registrant's Certifying Accountant
7:30am
8-K
ACST
Acasti Pharma Inc - Ordinary Shares
13 Nov 23
Acasti Announces Second Quarter 2024 Financial Results and Business Highlights
12:00am
8-K
l2yc64qsln r86j3u4
23 Oct 23
Acasti Announces Dosing of First Patient in GTX-104 STRIVE-ON Trial
4:30pm
8-K
rbm j5t5dijp1m
11 Oct 23
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
1isczg 5u2h9
26 Sep 23
Acasti Announces $7.5 Million Private Placement Equity Financing
8:10am
8-K
fu89cuh
11 Aug 23
Acasti Announces First Quarter 2024 Financial Results and Business Highlights
7:31am
8-K
kln6f288spd9m7cd4qvv
24 Jul 23
Other Events
5:30pm
8-K
ehi7lzhu2
7 Jul 23
Acasti Pharma Announces 1-for-6 Reverse Stock Split
8:30am
8-K
n045cjeb
5 Jul 23
Other Events
4:00pm
8-K
nc2juwr9e6gug5bsk
23 Jun 23
Acasti Pharma Reports Fiscal Year 2023 Operational Results
7:31am
8-K
hl0q7o esx
11 May 23
Departure of Directors or Certain Officers
4:50pm
8-K
fycznk 1rnd
5 Apr 23
Acasti Announces Appointment of Prashant Kohli as CEO
5:00pm
8-K
nm0sr1rgpiw6
31 Mar 23
Departure of Directors or Certain Officers
4:39pm
8-K
77jjrkg
13 Mar 23
Acasti Pharma Inc. Centralizes Marketplace for Shares on the Nasdaq with Voluntary Delisting from TSX Venture Exchange
8:04am
8-K
waj4if
22 Feb 23
Changes in Registrant's Certifying Accountant
6:15pm
8-K
snapwsc
14 Feb 23
Acasti Pharma Reports Third Quarter 2023 Operational Results
7:23am
8-K
cbjpsjd
25 Jan 23
Other Events
4:10pm